11.    References

  • (1995). Tetanus vaccine may be laced with anti-fertility drug. International / developing countries. Vaccine Wkly, 9-10.
  • Aal, A. (2021). Drugs Shown to Inhibit SARS-CoV-2 in COVID-19 Disease: Comparative Basic and Clinical Pharmacology of Molnupiravir and Ivermectin. Austin J Pharmacol Ther.
  • Abaluck, J., Kwong, L.H., Styczynski, A., Haque, A., Kabir, A., Bates-Jeffries, E., Crawford, E., Benjamin Chung, J., Raihan, S., Rahman, S., Benhachmi, S., Zaman, N., Winch, P.J., Hossain, M., Reza, H., All Jaber, A., Momen, S.G., Bani, F.L., Rahman, A., Huq, T.S., Luby, S.P., and Mobarak, A.M. (2021). The Impact of Community Masking on COVID-19: A Cluster-Randomized Trial in Bangladesh.
  • Abu-Raddad, L.J., Chemaitelly, H., Ayoub, H.H., Yassine, H.M., Benslimane, F.M., Al Khatib, H.A., Tang, P., Hasan, M.R., Coyle, P., Al Kanaani, Z., Al Kuwari, E., Jeremijenko, A., Kaleeckal, A.H., Latif, A.N., Shaik, R.M., Abdul Rahim, H.F., Nasrallah, G.K., Al Kuwari, M.G., Butt, A.A., Al Romaihi, H.E., Al-Thani, M.H., Al Khal, A., and Bertollini, R. (2021). Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar. JAMA.
  • Abu-Raddad, L.J., Chemaitelly, H., Bertollini, R., and National Study Group For, C.-E. (2021b). Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections. N Engl J Med.
  • Acharya, C.B., Schrom, J., Mitchell, A.M., Coil, D.A., Marquez, C., Rojas, S., Wang, C.Y., Liu, J., Pilarowski, G., Solis, L., Georgian, E., Petersen, M., Derisi, J., Michelmore, R., and Havlir, D. (2021). No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups When Infected with SARS-CoV-2 Delta Variant.
  • Ader, F., Bouscambert-Duchamp, M., Hites, M., Peiffer-Smadja, N., et al. (2021). Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, openlabel trial. The Lancet Infectious Diseases.
  • Aiello, A.E., Murray, G.F., Perez, V., Coulborn, R.M., Davis, B.M., Uddin, M., Shay, D.K., Waterman, S.H., and Monto, A.S. (2010). Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. J Infect Dis 201, 491-498.
  • Aiello, A.E., Perez, V., Coulborn, R.M., Davis, B.M., Uddin, M., and Monto, A.S. (2012). Facemasks, hand hygiene, and influenza among young adults: a randomized intervention trial. PLoS One 7, e29744.
  • Akinosoglou, K., Tzivaki, I., and Marangos, M. (2021). Covid-19 vaccine and autoimmunity: Awakening the sleeping dragon. Clin Immunol 226, 108721.
  • Al-Beltagi, S., Preda, C.A., Goulding, L.V., James, J., Pu, J., Skinner, P., Jiang, Z., Wang, B.L., Yang, J., Banyard, A.C., Mellits, K.H., Gershkovich, P., Hayes, C.J., Nguyen-Van-Tam, J., Brown, I.H., Liu, J., and Chang, K.C. (2021). Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus. Viruses 13.
  • Alcala-Diaz, J.F., Limia-Perez, L., Gomez-Huelgas, R., Martin-Escalante, M.D., Cortes-Rodriguez, B., Zambrana-Garcia, J.L., Entrenas-Castillo, M., Perez-Caballero, A.I., Lopez-Carmona, M.D., GarciaAlegria, J., Lozano Rodriguez-Mancheno, A., Arenas-De Larriva, M.D.S., Perez-Belmonte, L.M., Jungreis, I., Bouillon, R., Quesada-Gomez, J.M., and Lopez-Miranda, J. (2021). Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study. Nutrients 13.
  • Alfelali, M., Haworth, E.A., Barasheed, O., Badahdah, A.M., Bokhary, H., Tashani, M., Azeem, M.I., Kok, J., Taylor, J., Barnes, E.H., El Bashir, H., Khandaker, G., Holmes, E.C., Dwyer, D.E., Heron, L.G., Wilson, G.J., Booy, R., Rashid, H., and Hajj Research, T. (2020). Facemask against viral respiratory infections among Hajj pilgrims: A challenging cluster-randomized trial. PLoS One 15, e0240287.
  • Ali, N. (2020). Role of vitamin D in preventing of COVID-19 infection, progression and severity. J Infect Public Health 13, 1373-1380.
  • Allen, D.W. (2021). Covid Lockdown Cost/Benefits: A Critical Assessment of the Literature.
  • Ammar, A., Brach, M., Trabelsi, K., Chtourou, H., Boukhris, O., Masmoudi, L., Bouaziz, B., Bentlage, E., et al. (2020). Effects of COVID-19 Home Confinement on Eating Behaviour and Physical Activity: Results of the ECLB-COVID19 International Online Survey. Nutrients 12.
  • Andoh, R. (2021). “Final Response Letter (#21-02152-FOIA)”. (New York, NY: Siri & Glimstad).
  • Arefin, M.K. (2021). Povidone Iodine (PVP-I) Oro-Nasal Spray: An Effective Shield for COVID-19 Protection for Health Care Worker (HCW), for all. Indian J Otolaryngol Head Neck Surg, 1-6.
  • Arora, P., Rocha, C., Kempf, A., Nehlmeier, I., Graichen, L., Winkler, M.S., Lier, M., Schulz, S., Jack, H.M., Cossmann, A., Stankov, M.V., Behrens, G.M.N., Pohlmann, S., and Hoffmann, M. (2021). The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency. Cell Mol Immunol.
  • Arshad, S., Kilgore, P., Chaudhry, Z.S., Jacobsen, G., Wang, D.D., Huitsing, K., Brar, I., Alangaden, G.J., Ramesh, M.S., Mckinnon, J.E., O’neill, W., Zervos, M., and Henry Ford, C.-T.F. (2020). Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. Int J Infect Dis 97, 396-403.
  • Axfors, C., and Ioannidis, J.P.A. (2021). Infection fatality rate of COVID-19 in community-dwelling populations with emphasis on the elderly: An overview.
  • Bahl, P., Doolan, C., De Silva, C., Chughtai, A.A., Bourouiba, L., and Macintyre, C.R. (2020). Airborne or droplet precautions for health workers treating COVID-19? J Infect Dis.
  • Barbisch, D., Koenig, K.L., and Shih, F.Y. (2015). Is There a Case for Quarantine? Perspectives from SARS to Ebola. Disaster Med Public Health Prep 9, 547-553.
  • Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., Hernan, M.A., Lipsitch, M., Kohane, I., Netzer, D., Reis, B.Y., and Balicer, R.D. (2021). Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. N Engl J Med 385, 1078-1090.
  • Beigel, J.H., Tomashek, K.M., Dodd, L.E., Mehta, A.K., Zingman, B.S., Kalil, A.C., Hohmann, E., Chu, H.Y., Luetkemeyer, A., Kline, S., Lopez De Castilla, D., Finberg, R.W., Dierberg, K., Tapson, V., Hsieh, L., Patterson, T.F., Paredes, R., Sweeney, D.A., Short, W.R., Touloumi, G., Lye, D.C., Ohmagari, N., Oh, M.D., Ruiz-Palacios, G.M., Benfield, T., Fatkenheuer, G., Kortepeter, M.G., Atmar, R.L., Creech, C.B., Lundgren, J., Babiker, A.G., Pett, S., Neaton, J.D., Burgess, T.H., Bonnett, T., Green, M., Makowski, M., Osinusi, A., Nayak, S., Lane, H.C., and Members, A.-S.G. (2020). Remdesivir for the Treatment of Covid-19 – Final Report. N Engl J Med 383, 1813-1826.
  • Berbic, M., and Fraser, I.S. (2013). Immunology of normal and abnormal menstruation. Womens Health (Lond) 9, 387-395.
  • Bhatti, A.B., and Haq, A.U. (2017). The Pathophysiology of Perceived Social Isolation: Effects on Health and Mortality. Cureus 9, e994.
  • Bilezikian, J.P., Bikle, D., Hewison, M., Lazaretti-Castro, M., Formenti, A.M., Gupta, A., Madhavan, M.V., Nair, N., Babalyan, V., Hutchings, N., Napoli, N., Accili, D., Binkley, N., Landry, D.W., and Giustina, A. (2020). MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19. Eur J Endocrinol 183, R133-R147.
  • Bilich, T., Nelde, A., Heitmann, J.S., Maringer, Y., Roerden, M., Bauer, J., Rieth, J., Wacker, M., Peter, A., Horber, S., Rachfalski, D., Marklin, M., Stevanovic, S., Rammensee, H.G., Salih, H.R., and Walz, J.S. (2021). T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals. Sci Transl Med 13.
  • Borger, P., Malhotra, R.K., Yeadon, M., Craig, C., Mckernan, K., Steger, K., Mcsheehy, P., Angelova, L., Franchi, F., Binder, T., Ullrich, H., Ohashi, M., Scoglio, S., Doesburg-Van Kleffens, M.G., D. , Klement, R.J., Schruefer, R., Pieksma, B.W., Bonte, J., Dalle Carbonara, B.H., Corbett, K.P., and Kämmerer, U. (2020). External peer review of the RTPCR test to detect SARS-CoV-2 reveals 10 major scientific flaws at the molecular and methodological level: consequences for false positive results.
  • Borsche, L., Glauner, B., and Von Mendel, J. (2021). COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis. Nutrients 13.
  • Brazeau, N.F., Verity, R., Jenks, S., Fu, H., Whittaker, C., Winskill, P., Dorigatti, I., Walker, P., Riley, S., Schnekenberg, R.P., Hoeltgebaum, H., Mellan, T.A., Mishra, S., Unwin, H.J.T., Watson, O.J., Cucunubá, Z.M., Baguelin, M., Whittles, L., Bhatt, S., Ghani, A.Z., Ferguson, N.M., and Okell, L.C. (2020). Report 34: COVID-19 Infection Fatality Ratio: Estimates from Seroprevalence. Imperial College London.
  • Bridgland, V.M.E., Moeck, E.K., Green, D.M., Swain, T.L., Nayda, D.M., Matson, L.A., Hutchison, N.P., and Takarangi, M.K.T. (2021). Why the COVID-19 pandemic is a traumatic stressor. PLoS One 16, e0240146.
  • Brooks, S.K., Webster, R.K., Smith, L.E., Woodland, L., Wessely, S., Greenberg, N., and Rubin, G.J. (2020). The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 395, 912-920.
  • Brown, C.M., Vostok, J., Johnson, H., Burns, M., Gharpure, R., Sami, S., Sabo, R.T., Hall, N., Foreman, A., Schubert, P.L., Gallagher, G.R., Fink, T., Madoff, L.C., Gabriel, S.B., Macinnis, B., Park, D.J., Siddle, K.J., Harik, V., Arvidson, D., Brock-Fisher, T., Dunn, M., Kearns, A., and Laney, A.S. (2021). Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings – Barnstable County, Massachusetts, July 2021. MMWR Morb Mortal Wkly Rep 70, 1059-1062.
  • Bryant, A., Lawrie, T.A., Dowswell, T., Fordham, E.J., Mitchell, S., Hill, S.R., and Tham, T.C. (2021). Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. Am J Ther 28, e434-e460.
  • Buitrago-Garcia, D., Egli-Gany, D., Counotte, M.J., Hossmann, S., Imeri, H., Ipekci, A.M., Salanti, G., and Low, N. (2020). Occurrence and transmission potential of asymptomatic and presymptomatic SARSCoV-2 infections: A living systematic review and meta-analysis. PLoS Med 17, e1003346.
  • Bundgaard, H., Bundgaard, J.S., Raaschou-Pedersen, D.E.T., Von Buchwald, C., Todsen, T., Norsk, J.B., PriesHeje, M.M., Vissing, C.R., Nielsen, P.B., Winslow, U.C., Fogh, K., Hasselbalch, R., Kristensen, J.H., Ringgaard, A., Porsborg Andersen, M., Goecke, N.B., Trebbien, R., Skovgaard, K., Benfield, T., Ullum, H., Torp-Pedersen, C., and Iversen, K. (2021). Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial. Ann Intern Med 174, 335-343.
  • Burgess, A., and Horii, M. (2012). Risk, ritual and health responsibilisation: Japan’s ‘safety blanket’ of surgical face mask-wearing. Sociol Health Illn 34, 1184-1198.
  • Caly, L., Druce, J.D., Catton, M.G., Jans, D.A., and Wagstaff, K.M. (2020). The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res 178, 104787.
  • Capozzo, A.V. (2020). Dying Alone Due to COVID-19: Do the Needs of the Many Outweigh the Rights of the Few-or the One? Front Public Health 8, 593464.
  • Carbon, C.C. (2020). Wearing Face Masks Strongly Confuses Counterparts in Reading Emotions. Front Psychol 11, 566886.
  • Cardozo, T., and Veazey, R. (2021). Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease. Int J Clin Pract 75, e13795.
  • Cattoli, G., Fusaro, A., Monne, I., Coven, F., Joannis, T., El-Hamid, H.S., Hussein, A.A., Cornelius, C., Amarin, N.M., Mancin, M., Holmes, E.C., and Capua, I. (2011). Evidence for differing evolutionary dynamics of A/H5N1 viruses among countries applying or not applying avian influenza vaccination in poultry. Vaccine 29, 9368-9375.
  • Cdc (07/21/2021). Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing.
  • Cdc (2020a). Conditions contributing to deaths involving COVID-19, by age group, United States. Week ending 2/1/2020 to 12/5/2020.
  • Cdc (2020b). Overdose Deaths Accelerating During COVID-19.
  • Cdc Covid-Vaccine Breakthrough Case Investigations Team (2021). COVID-19 Vaccine Breakthrough Infections Reported to CDC – United States, January 1-April 30, 2021. MMWR Morb Mortal Wkly Rep 70, 792-793.
  • Cevik, M., Tate, M., Lloyd, O., Maraolo, A.E., Schafers, J., and Ho, A. (2021). SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe 2, e13-e22.
  • Chapman, M.R., and Vause, H.E. (2011). Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry 168, 245-251.
  • Charbonnier, E., Le Vigouroux, S., and Goncalves, A. (2021). Psychological Vulnerability of French University Students during the COVID-19 Pandemic: A Four-Wave Longitudinal Survey. Int J Environ Res Public Health 18.
  • Chemaitelly, H., Tang, P., Hasan, M.R., Almukdad, S., Yassine, H.M., Benslimane, F.M., Al Khatib, H.A., Coyle, P., Ayoub, H.H., Al Kanaani, Z., Al Kuwari, E., Jeremijenko, A., Kaleeckal, A.H., Latif, A.N., Shaik, R.M., Abdul Rahim, H.F., Nasrallah, G.K., Al Kuwari, M.G., Al Romaihi, H.E., Butt, A.A., Al-Thani, M.H., Al Khal, A., Bertollini, R., and Abu-Raddad, L.J. (2021). Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar. New England Journal of Medicine.
  • Cheng, V.C., Wong, S.C., Chuang, V.W., So, S.Y., Chen, J.H., Sridhar, S., To, K.K., Chan, J.F., Hung, I.F., Ho, P.L., and Yuen, K.Y. (2020). The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2. J Infect 81, 107-114.
  • Choudhury, A., Das, N.C., Patra, R., Bhattacharya, M., Ghosh, P., Patra, B.C., and Mukherjee, S. (2021). Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach. Future Virology 16, 277-291.
  • Chow, J.H., Khanna, A.K., Kethireddy, S., Yamane, D., Levine, A., Jackson, A.M., Mccurdy, M.T., et al. (2021). Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019. Anesth Analg 132, 930-941.
  • Chowdhury, A.M.M., Shahbaz, M., Karim, M.R., Islam, J., Dan, G., and He, S.X. (2021). A Comparative Study on Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin Therapy on COVID-19 Patients. Eurasian Journal of Medicine and Oncology 5, 63-70.
  • Christou, E.a.A., Giardino, G., Stefanaki, E., and Ladomenou, F. (2019). Asthma: An Undermined State of Immunodeficiency. Int Rev Immunol 38, 70-78.
  • Cohen, K.W., Linderman, S.L., Moodie, Z., Czartoski, J., Lai, L., Mantus, G., Norwood, C., Nyhoff, L.E., et al. (2021). Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells. Cell Rep Med 2, 100354.
  • Cohn, B.A., Cirillo, P.M., Murphy, C.C., Krigbaum, N.Y., and Wallace, A.W. (2021). SARS-CoV-2 vaccine protection and deaths among US veterans during 2021. Science, eabm0620.
  • Colson, P., Rolain, J.M., Lagier, J.C., Brouqui, P., and Raoult, D. (2020). Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents 55, 105932.
  • Corman, V.M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D.K., Bleicker, T., Brunink, S., Schneider, J., Schmidt, M.L., Mulders, D.G., Haagmans, B.L., Van Der Veer, B., Van Den Brink, S., Wijsman, L., Goderski, G., Romette, J.L., Ellis, J., Zambon, M., Peiris, M., Goossens, H., Reusken, C., Koopmans, M.P., and Drosten, C. (2020). Detection of 2019 novel coronavirus (2019-nCoV) by realtime RT-PCR. Euro Surveill 25.
  • Critchley, H.D., Daly, E.M., Bullmore, E.T., Williams, S.C., Van Amelsvoort, T., Robertson, D.M., Rowe, A., Phillips, M., Mcalonan, G., Howlin, P., and Murphy, D.G. (2000). The functional neuroanatomy of social behaviour: changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain 123 ( Pt 11), 2203-2212.
  • Crump, A., and Omura, S. (2011). Ivermectin, ‘wonder drug’ from Japan: the human use perspective. Proc Jpn Acad Ser B Phys Biol Sci 87, 13-28.
  • Czeisler, M.E., Lane, R.I., Petrosky, E., Wiley, J.F., Christensen, A., Njai, R., Weaver, M.D., Robbins, R., Facer-Childs, E.R., Barger, L.K., Czeisler, C.A., Howard, M.E., and Rajaratnam, S.M.W. (2020). Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic – United States, June 24-30, 2020. MMWR Morb Mortal Wkly Rep 69, 1049-1057.
  • Czypionka, T., Greenhalgh, T., Bassler, D., and Bryant, M.B. (2021). Masks and Face Coverings for the Lay Public : A Narrative Update. Ann Intern Med 174, 511-520.
  • Dagan, N., Barda, N., and Balicer, R.D. (2021). Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex. New England Journal of Medicine.
  • Dan, J.M., Mateus, J., Kato, Y., Hastie, K.M., Yu, E.D., Faliti, C.E., Grifoni, A., Ramirez, S.I., Haupt, S., Frazier, A., Nakao, C., Rayaprolu, V., Rawlings, S.A., Peters, B., Krammer, F., Simon, V., Saphire, E.O., Smith, D.M., Weiskopf, D., Sette, A., and Crotty, S. (2021). Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science 371.
  • Denison, M.R., Graham, R.L., Donaldson, E.F., Eckerle, L.D., and Baric, R.S. (2011). Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity. RNA Biol 8, 270-279.
  • Deoni, S.C., Beauchemin, J., Volpe, A., Da Sa, V., and Consortium, R. (2021). Impact of the COVID-19 Pandemic on Early Child Cognitive Development: Initial Findings in a Longitudinal Observational Study of Child Health. medRxiv.
  • Dhabhar, F.S. (2009). Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmunomodulation 16, 300-317.
  • Di Fusco, M., Moran, M.M., Cane, A., Curcio, D., Khan, F., Malhotra, D., Surinach, A., Miles, A., Swerdlow, D., Mclaughlin, J.M., and Nguyen, J.L. (2021). Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2. Journal of Medical Economics 24, 1248-1260.
  • Di Pierro, F., Derosa, G., Maffioli, P., Bertuccioli, A., Togni, S., Riva, A., Allegrini, P., Khan, A., Khan, S., Khan, B.A., Altaf, N., Zahid, M., Ujjan, I.D., Nigar, R., Khushk, M.I., Phulpoto, M., Lail, A., Devrajani, B.R., and Ahmed, S. (2021a). Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study. Int J Gen Med 14, 2359-2366.
  • Di Pierro, F., Iqtadar, S., Khan, A., Ullah Mumtaz, S., Masud Chaudhry, M., Bertuccioli, A., Derosa, G., Maffioli, P., Togni, S., Riva, A., Allegrini, P., and Khan, S. (2021b). Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial. Int J Gen Med 14, 2807-2816.
  • Dilber, E., Karagoz, T., Aytemir, K., Ozer, S., Alehan, D., Oto, A., and Celiker, A. (2003). Acute myocarditis associated with tetanus vaccination. Mayo Clin Proc 78, 1431-1433.
  • Dinesh Kumar, N., Ter Ellen, B.M., Bouma, E.M., Troost, B., Van De Pol, D.P.I., Van Der Ende-Metselaar, H.H., Van Gosliga, D., Apperloo, L., Carpaij, O.A., Van Den Berge, M., Nawijn, M.C., Stienstra, Y., Rodenhuis-Zybert, I.A., and Smit, J.M. (2021). Moxidectin and Ivermectin Inhibit Sars-Cov-2 Replication in Vero E6 Cells but Not in Human Primary Airway Epithelium Cells. Antimicrob Agents Chemother, AAC0154321.
  • Doshi, P. (2020). Will covid-19 vaccines save lives? Current trials aren’t designed to tell us. BMJ 371, m4037.
  • Doshi, P. (2021). Covid-19 vaccines: In the rush for regulatory approval, do we need more data? BMJ 373, n1244.
  • Dror, A.A., Morozov, N.G., Daoud, A., Namir, Y., Orly, Y., Shachar, Y., Lifshitz, M., Segal, E., Fischer, L., Mizrachi, M., Eisenbach, N., Rayan, D., Gruber, M., Bashkin, A., Kaykov, E., Barhoum, M., Edelstein, M., and Sela, E. (2021). Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness.
  • Dyer, O. (2021). Covid-19: Regulators warn that rare Guillain-Barre cases may link to J&J and AstraZeneca vaccines. BMJ 374, n1786.
  • Earle, K.A., Ambrosino, D.M., Fiore-Gartland, A., Goldblatt, D., Gilbert, P.B., Siber, G.R., Dull, P., and Plotkin, S.A. (2021). Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine 39, 4423-4428.
  • Eberhardt, C.S., and Siegrist, C.A. (2021). Is there a role for childhood vaccination against COVID-19? Pediatr Allergy Immunol 32, 9-16.
  • Entrenas Castillo, M., Entrenas Costa, L.M., Vaquero Barrios, J.M., Alcala Diaz, J.F., Lopez Miranda, J., Bouillon, R., and Quesada Gomez, J.M. (2020). “Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”. J Steroid Biochem Mol Biol 203, 105751.
  • Esterwood, E., and Saeed, S.A. (2020). Past Epidemics, Natural Disasters, COVID19, and Mental Health: Learning from History as we Deal with the Present and Prepare for the Future. Psychiatr Q 91, 1121-1133.
  • European Medicines Agency Committee for Medicinal Products for Human Use (Chmp) (2021a). Comirnaty – COVID-19 mRNA vaccine (nucleoside-modified) Assessment Report. EMA/707383/2020 Corr.1.
  • European Medicines Agency Committee for Medicinal Products for Human Use (Chmp) (2021b). COVID-19 Vaccine Moderna – COVID-19 mRNA Vaccine (nucleoside-modified) Assessment Report. EMEA/H/C/005791/0000.
  • Farrell, N.F., Klatt-Cromwell, C., and Schneider, J.S. (2020). Benefits and Safety of Nasal Saline Irrigations in a Pandemic-Washing COVID-19 Away. JAMA Otolaryngol Head Neck Surg 146, 787-788.
  • Fauci, A.S. (2012). Research on highly pathogenic H5N1 influenza virus: the way forward. mBio 3.
  • Fauci, A.S., Lane, H.C., and Redfield, R.R. (2020). Covid-19 – Navigating the Uncharted. N Engl J Med 382, 1268-1269.
  • Fennelly, K.P. (2020). Particle sizes of infectious aerosols: implications for infection control. Lancet Respir Med 8, 914-924.
  • Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., and Laufs, U. (2020). Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clin Res Cardiol 109, 1522-1530.
  • Fiorillo, A., Sampogna, G., Giallonardo, V., Del Vecchio, V., Luciano, M., Albert, U., Carmassi, C., Carra, G., Cirulli, F., Dell’osso, B., Nanni, M.G., Pompili, M., Sani, G., Tortorella, A., and Volpe, U. (2020). Effects of the lockdown on the mental health of the general population during the COVID-19 pandemic in Italy: Results from the COMET collaborative network. Eur Psychiatry 63, e87.
  • Flannery, P., Yang, I., Keyvani, M., and Sakoulas, G. (2021). Acute Psychosis Due to Anti-N-Methyl D-Aspartate Receptor Encephalitis Following COVID-19 Vaccination: A Case Report. Front Neurol 12, 764197.
  • Föhse, F.K., Geckin, B., Overheul, G.J., Van De Maat, J., Kilic, G., Bulut, O., Dijkstra, H., Lemmers, H., Sarlea, S.A., Reijnders, M., Hoogerwerf, J., Oever, J.T., Simonetti, E., Van De Veerdonk, F.L., Joosten, L.a.B., Haagmans, B.L., Van Crevel, R., Li, Y., Van Rij, R.P., Geurtsvankessel, C., De Jonge, M.I., Domínguez-Andrés, J., and Netea, M.G. (2021). The BNT162b2 mRNA vaccine against SARS-CoV-2 reprograms both adaptive and innate immune responses.
  • Formiga, F.R., Leblanc, R., De Souza Reboucas, J., Farias, L.P., De Oliveira, R.N., and Pena, L. (2021). Ivermectin: an award-winning drug with expected antiviral activity against COVID-19. J Control Release 329, 758-761.
  • French National Academy of Medicine (2020). “Vitamin D and Covid-19”.
  • Gaebler, C., Wang, Z., Lorenzi, J.C.C., Muecksch, F., Finkin, S., Tokuyama, M., et al. (2021). Evolution of antibody immunity to SARS-CoV-2. Nature 591, 639-644.
  • Galea, S., Merchant, R.M., and Lurie, N. (2020). The Mental Health Consequences of COVID-19 and Physical Distancing: The Need for Prevention and Early Intervention. JAMA Intern Med 180, 817-818.
  • Gao, J., Tian, Z., and Yang, X. (2020). Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 14, 72-73.
  • Gazit, S., Shlezinger, R., Perez, G., Lotan, R., Peretz, A., Ben-Tov, A., Cohen, D., Muhsen, K., Chodick, G., and Patalon, T. (2021). Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections.
  • Gerard, A.O., Laurain, A., Fresse, A., Parassol, N., Muzzone, M., Rocher, F., Esnault, V.L.M., and Drici, M.D. (2021). Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database. Clin Pharmacol Ther 109, 1021-1024.
  • Gismero-Gonzalez, E., Bermejo-Toro, L., Cagigal, V., Roldan, A., Martinez-Beltran, M.J., and Halty, L. (2020). Emotional Impact of COVID-19 Lockdown Among the Spanish Population. Front Psychol 11, 616978.
  • Giubilini, A., Gupta, S., and Heneghan, C. (2021). A focused protection vaccination strategy: why we should not target children with COVID-19 vaccination policies. J Med Ethics 47, 565-566.
  • Glober, N., Mohler, G., Huynh, P., Arkins, T., O’donnell, D., Carter, J., and Ray, B. (2020). Impact of COVID19 Pandemic on Drug Overdoses in Indianapolis. J Urban Health 97, 802-807.
  • Goldman, E. (2021). How the unvaccinated threaten the vaccinated for COVID-19: A Darwinian perspective. Proceedings of the National Academy of Sciences 118.
  • Goldman, J.D., Lye, D.C.B., Hui, D.S., Marks, K.M., Bruno, R., Montejano, R., Spinner, C.D., Galli, M., Ahn, M.Y., Nahass, R.G., Chen, Y.S., Sengupta, D., Hyland, R.H., Osinusi, A.O., Cao, H., Blair, C., Wei, X., Gaggar, A., Brainard, D.M., Towner, W.J., Munoz, J., Mullane, K.M., Marty, F.M., Tashima, K.T., Diaz, G., Subramanian, A., and Investigators, G.-U.-. (2020). Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. N Engl J Med 383, 1827-1837.
  • Gonzalez Canga, A., Sahagun Prieto, A.M., Diez Liebana, M.J., Fernandez Martinez, N., Sierra Vega, M., and Garcia Vieitez, J.J. (2008). The pharmacokinetics and interactions of ivermectin in humans–a minireview. AAPS J 10, 42-46.
  • Grant, W.B., Lahore, H., Mcdonnell, S.L., Baggerly, C.A., French, C.B., Aliano, J.L., and Bhattoa, H.P. (2020). Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients 12.
  • Greene, M.W., Roberts, A.P., and Fruge, A.D. (2021). Negative Association Between Mediterranean Diet Adherence and COVID-19 Cases and Related Deaths in Spain and 23 OECD Countries: An Ecological Study. Front Nutr 8, 591964.
  • Grifoni, A., Weiskopf, D., Ramirez, S.I., Mateus, J., Dan, J.M., Moderbacher, C.R., Rawlings, S.A., et al. (2020). Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell 181, 1489-1501 e1415.
  • Guenezan, J., Garcia, M., Strasters, D., Jousselin, C., Leveque, N., Frasca, D., and Mimoz, O. (2021). Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg 147, 400-401.
  • Guerra, D.D., and Guerra, D.J. (2021). Mask mandate and use efficacy for COVID-19 containment in US States. International Research Journal of Public Health 5.
  • Gupta, S.K., and Bansal, P. (2010). Vaccines for immunological control of fertility. Reprod Med Biol 9, 61-71.
  • Guy, G.P., Jr., Lee, F.C., Sunshine, G., Mccord, R., Howard-Williams, M., Kompaniyets, L., Dunphy, C., Gakh, M., Weber, R., Sauber-Schatz, E., Omura, J.D., Massetti, G.M., Cdc Covid-19 Response Team, M.P.a.U., and Program, C.D.C.P.H.L. (2021). Association of State-Issued Mask Mandates and Allowing On-Premises Restaurant Dining with County-Level COVID-19 Case and Death Growth Rates – United States, March 1-December 31, 2020. MMWR Morb Mortal Wkly Rep 70, 350-354.
  • Guzzo, C.A., Furtek, C.I., Porras, A.G., Chen, C., Tipping, R., Clineschmidt, C.M., Sciberras, D.G., Hsieh, J.Y., and Lasseter, K.C. (2002). Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J Clin Pharmacol 42, 1122-1133.
  • Haley, D.F., and Saitz, R. (2020). The Opioid Epidemic During the COVID-19 Pandemic. JAMA 324, 1615-1617.
  • Hammen, C., Kim, E.Y., Eberhart, N.K., and Brennan, P.A. (2009). Chronic and acute stress and the prediction of major depression in women. Depress Anxiety 26, 718-723.
  • Hamming, I., Timens, W., Bulthuis, M.L., Lely, A.T., Navis, G., and Van Goor, H. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203, 631-637.
  • Hartenian, E., Nandakumar, D., Lari, A., Ly, M., Tucker, J.M., and Glaunsinger, B.A. (2020). The molecular virology of coronaviruses. J Biol Chem 295, 12910-12934.
  • Haveri, A., Ekstrom, N., Solastie, A., Virta, C., Osterlund, P., Isosaari, E., Nohynek, H., Palmu, A.A., and Melin, M. (2021). Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans. Eur J Immunol.
  • Hawryluck, L., Gold, W.L., Robinson, S., Pogorski, S., Galea, S., and Styra, R. (2004). SARS control and psychological effects of quarantine, Toronto, Canada. Emerg Infect Dis 10, 1206-1212.
  • Heidary, F., and Gharebaghi, R. (2020). Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen. J Antibiot (Tokyo) 73, 593-602.
  • Hellwig, M.D., and Maia, A. (2021). A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin. Int J Antimicrob Agents 57, 106248.
  • Hoertel, N., Sanchez-Rico, M., Vernet, R., Beeker, N., Jannot, A.S., Neuraz, A., Salamanca, E., Paris, N., Daniel, C., Gramfort, A., Lemaitre, G., Bernaux, M., Bellamine, A., Lemogne, C., Airagnes, G., Burgun, A., Limosin, F., Collaboration, A.-H.U.I.C.-R., and Initiative, A.-H.C.C. (2021). Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Mol Psychiatry.
  • Hoffmann, M., Kleine-Weber, H., Schroeder, S., Kruger, N., Herrler, T., Erichsen, S., Schiergens, T.S., Herrler, G., Wu, N.H., Nitsche, A., Muller, M.A., Drosten, C., and Pohlmann, S. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181, 271-280 e278.
  • Hojyo, S., Uchida, M., Tanaka, K., Hasebe, R., Tanaka, Y., Murakami, M., and Hirano, T. (2020). How COVID-19 induces cytokine storm with high mortality. Inflamm Regen 40, 37.
  • Horigian, V.E., Schmidt, R.D., and Feaster, D.J. (2021). Loneliness, Mental Health, and Substance Use among US Young Adults during COVID-19. J Psychoactive Drugs 53, 1-9.
  • Infante, M., Buoso, A., Pieri, M., Lupisella, S., Nuccetelli, M., Bernardini, S., Fabbri, A., Iannetta, M., Andreoni, M., Colizzi, V., and Morello, M. (2021). Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study. J Am Coll Nutr, 1-16.
  • Ioannidis, J.P.A. (2021). Infection fatality rate of COVID-19 inferred from seroprevalence data. Bull World Health Organ 99, 19-33F.
  • Isaacs, D., Britton, P., Howard-Jones, A., Kesson, A., Khatami, A., Marais, B., Nayda, C., and Outhred, A. (2020). Do facemasks protect against COVID-19? J Paediatr Child Health 56, 976-977.
  • Ismailova, A., and White, J.H. (2021). Vitamin D, infections and immunity. Rev Endocr Metab Disord.
  • Ivmmeta.Com (2021). Ivermectin for COVID-19: real-time meta analysis of 63 studies [Online]. Available: https://ivmmeta.com/ [Accessed 09/07/2021 2021].
  • Jaafar, R., Aherfi, S., Wurtz, N., Grimaldier, C., Van Hoang, T., Colson, P., Raoult, D., and La Scola, B. (2021). Correlation Between 3790 Quantitative Polymerase Chain Reaction-Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates. Clin Infect Dis 72, e921.
  • Jacobs, J.L., Ohde, S., Takahashi, O., Tokuda, Y., Omata, F., and Fukui, T. (2009). Use of surgical face masks to reduce the incidence of the common cold among health care workers in Japan: a randomized controlled trial. Am J Infect Control 37, 417-419.
  • Jain, A., Chaurasia, R., Sengar, N.S., Singh, M., Mahor, S., and Narain, S. (2020). Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers. Sci Rep 10, 20191.
  • Janaskie, A., and Earle, P.C. (2020). The Devastating Economic Impact of Covid-19 Shutdowns. American Institute for Economic Research.
  • Jans, D.A., and Wagstaff, K.M. (2020). Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal? Cells 9.
  • Jiang, H., and Mei, Y.F. (2021). SARS-CoV-2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro. Viruses 13.
  • Jing, Y., Run-Qian, L., Hao-Ran, W., Hao-Ran, C., Ya-Bin, L., Yang, G., and Fei, C. (2020). Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod 26, 367-373.
  • Jorgensen, S.C.J., Kebriaei, R., and Dresser, L.D. (2020). Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19. Pharmacotherapy 40, 659-671.
  • Ju, J.T.J., Boisvert, L.N., and Zuo, Y.Y. (2021). Face masks against COVID-19: Standards, efficacy, testing and decontamination methods. Adv Colloid Interface Sci 292, 102435.
  • Kampf, G. (2021a). COVID-19: stigmatising the unvaccinated is not justified. The Lancet 398.
  • Kampf, G. (2021b). The epidemiological relevance of the COVID-19-vaccinated population is increasing. The Lancet Regional Health – Europe 11.
  • Kanduc, D., and Shoenfeld, Y. (2020). On the molecular determinants of the SARS-CoV-2 attack. Clin Immunol 215, 108426.
  • Kao, T.W., Huang, K.C., Huang, Y.L., Tsai, T.J., Hsieh, B.S., and Wu, M.S. (2004). The physiological impact of wearing an N95 mask during hemodialysis as a precaution against SARS in patients with end-stage renal disease. J Formos Med Assoc 103, 624-628.
  • Keehner, J., Horton, L.E., Binkin, N.J., Laurent, L.C., Pride, D., Longhurst, C.A., Abeles, S.R., and Torriani, F.J. (2021). Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce. N Engl J Med.
  • Khayat-Khoei, M., Bhattacharyya, S., Katz, J., Harrison, D., Tauhid, S., Bruso, P., Houtchens, M.K., Edwards, K.R., and Bakshi, R. (2021). COVID-19 mRNA vaccination leading to CNS inflammation: a case series. J Neurol.
  • Khoury, D.S., Cromer, D., Reynaldi, A., Schlub, T.E., Wheatley, A.K., Juno, J.A., Subbarao, K., Kent, S.J., Triccas, J.A., and Davenport, M.P. (2021). Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med 27, 1205-1211.
  • Kisielinski, K., Giboni, P., Prescher, A., Klosterhalfen, B., Graessel, D., Funken, S., Kempski, O., and Hirsch, O. (2021). Is a Mask That Covers the Mouth and Nose Free from Undesirable Side Effects in Everyday Use and Free of Potential Hazards? Int J Environ Res Public Health 18.
  • Klimke, A., Hefner, G., Will, B., and Voss, U. (2020). Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection. Med Hypotheses 142, 109783.
  • Kohler, C.A., Freitas, T.H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., De Andrade, N.Q., Morris, G., Fernandes, B.S., Brunoni, A.R., Herrmann, N., Raison, C.L., Miller, B.J., Lanctot, K.L., and Carvalho, A.F. (2018). Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis. Mol Neurobiol 55, 4195-4206.
  • Kompaniyets, L., Goodman, A.B., Belay, B., Freedman, D.S., Sucosky, M.S., Lange, S.J., Gundlapalli, A.V., Boehmer, T.K., and Blanck, H.M. (2021). Body Mass Index and Risk for COVID-19-Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death – United States, March-December 2020. MMWR Morb Mortal Wkly Rep 70, 355-361.
  • Konda, A., Prakash, A., Moss, G.A., Schmoldt, M., Grant, G.D., and Guha, S. (2020). Aerosol Filtration Efficiency of Common Fabrics Used in Respiratory Cloth Masks. ACS Nano 14, 6339-6347.
  • Koob, G.F., and Schulkin, J. (2019). Addiction and stress: An allostatic view. Neurosci Biobehav Rev 106, 245-262.
  • Kostoff, R.N., Calina, D., Kanduc, D., Briggs, M.B., Vlachoyiannopoulos, P., Svistunov, A.A., and Tsatsakis, A. (2021). Why are we vaccinating children against COVID-19? Toxicol Rep 8, 1665-1684.
  • Kowalik, M. (2021). Ethics of vaccine refusal. J Med Ethics.
  • Kuhn, J.H., Li, W., Choe, H., and Farzan, M. (2004). Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus. Cell Mol Life Sci 61, 2738-2743.
  • Kumar, S., and Singh, A. (2021). Prolonged Use of n95 Mask a Boon or Bane to Healthcare Workers During Covid-19 Pandemic. Indian J Otolaryngol Head Neck Surg, 1-4.
  • Laing, R., Gillan, V., and Devaney, E. (2017). Ivermectin – Old Drug, New Tricks? Trends Parasitol 33, 463-472.
  • Lakkireddy, M., Gadiga, S.G., Malathi, R.D., Karra, M.L., Raju, I., Ragini, Chinapaka, S., Baba, K., and Kandakatla, M. (2021). Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease. Sci Rep 11, 10641.
  • Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., and Wang, X. (2020). Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215-220.
  • Lazzarino, A.I., Steptoe, A., Hamer, M., and Michie, S. (2020). Covid-19: Important potential side effects of wearing face masks that we should bear in mind. BMJ 369, m2003.
  • Le Bert, N., Tan, A.T., Kunasegaran, K., Tham, C.Y.L., Hafezi, M., Chia, A., Chng, M.H.Y., Lin, M., Tan, N., Linster, M., Chia, W.N., Chen, M.I., Wang, L.F., Ooi, E.E., Kalimuddin, S., Tambyah, P.A., Low, J.G., Tan, Y.J., and Bertoletti, A. (2020). SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 584, 457-462.
  • Lee, B.U. (2020). Minimum Sizes of Respiratory Particles Carrying SARS-CoV-2 and the Possibility of Aerosol Generation. Int J Environ Res Public Health 17.
  • Lee, W.S., Wheatley, A.K., Kent, S.J., and Dekosky, B.J. (2020). Antibody-dependent enhancement and SARSCoV-2 vaccines and therapies. Nat Microbiol 5, 1185-1191.
  • Levin, E.G., Lustig, Y., Cohen, C., Fluss, R., Indenbaum, V., Amit, S., Doolman, R., Asraf, K., Mendelson, E., Ziv, A., Rubin, C., Freedman, L., Kreiss, Y., and Regev-Yochay, G. (2021). Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months. New England Journal of Medicine.
  • Li, Y., Tokura, H., Guo, Y.P., Wong, A.S., Wong, T., Chung, J., and Newton, E. (2005). Effects of wearing N95 and surgical facemasks on heart rate, thermal stress and subjective sensations. Int Arch Occup Environ Health 78, 501-509.
  • Ling, S.F., Broad, E., Murphy, R., Pappachan, J.M., Pardesi-Newton, S., Kong, M.F., and Jude, E.B. (2020). High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study. Nutrients 12.
  • Liu, J., Wang, J., Xu, J., Xia, H., Wang, Y., Zhang, C., Chen, W., Zhang, H., Liu, Q., Zhu, R., Shi, Y., Shen, Z., Xing, Z., Gao, W., Zhou, L., Shao, J., Shi, J., Yang, X., Deng, Y., Wu, L., Lin, Q., Zheng, C., Zhu, W., Wang, C., Sun, Y.E., and Liu, Z. (2021a). Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines. Cell Discov 7, 99.
  • Liu, Y., Sawalha, A.H., and Lu, Q. (2021). COVID-19 and autoimmune diseases. Curr Opin Rheumatol 33, 155-162.
  • Lucchetti, G., Goes, L.G., Amaral, S.G., Ganadjian, G.T., Andrade, I., Almeida, P.O.A., Do Carmo, V.M., and Manso, M.E.G. (2020). Spirituality, religiosity and the mental health consequences of social isolation during Covid-19 pandemic. Int J Soc Psychiatry, 20764020970996.
  • Lyu, W., and Wehby, G.L. (2020). Community Use Of Face Masks And COVID-19: Evidence From A Natural Experiment Of State Mandates In The US. Health Aff (Millwood) 39, 1419-1425.
  • Macintyre, C.R., and Chughtai, A.A. (2020). A rapid systematic review of the efficacy of face masks and respirators against coronaviruses and other respiratory transmissible viruses for the community, healthcare workers and sick patients. Int J Nurs Stud 108, 103629.
  • Macintyre, C.R., Seale, H., Dung, T.C., Hien, N.T., Nga, P.T., Chughtai, A.A., Rahman, B., Dwyer, D.E., and Wang, Q. (2015). A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ Open 5, e006577.
  • Madison, A.A., Shrout, M.R., Renna, M.E., and Kiecolt-Glaser, J.K. (2021). Psychological and Behavioral Predictors of Vaccine Efficacy: Considerations for COVID-19. Perspect Psychol Sci 16, 191-203.
  • Male, V. (2021a). Are COVID-19 vaccines safe in pregnancy? Nat Rev Immunol 21, 200-201.
  • Male, V. (2021b). Menstrual changes after covid-19 vaccination. BMJ 374, n2211.
  • Mandelkorn, U., Genzer, S., Choshen-Hillel, S., Reiter, J., Meira, E.C.M., Hochner, H., Kheirandish-Gozal, L., Gozal, D., and Gileles-Hillel, A. (2021). Escalation of sleep disturbances amid the COVID-19 pandemic: a cross-sectional international study. J Clin Sleep Med 17, 45-53.
  • Marler, H., and Ditton, A. (2021). “I’m smiling back at you”: Exploring the impact of mask wearing on communication in healthcare. Int J Lang Commun Disord 56, 205-214.
  • Marschner, I.C. (2021). Estimating age-specific COVID-19 fatality risk and time to death by comparing population diagnosis and death patterns: Australian data. BMC Med Res Methodol 21, 126.
  • Martínez-Colón, G.J., Ratnasiri, K., Chen, H., Jiang, S., Zanley, E., Rustagi, A., Verma, R., Chen, H., Andrews, J.R., Mertz, K.D., Tzankov, A., Azagury, D., Boyd, J., Nolan, G.P., Schürch, C.M., Matter, M.S., Blish, C.A., and Mclaughlin, T.L. (2021). SARS-CoV-2 infects human adipose tissue and elicits an inflammatory response consistent with severe COVID-19.
  • Masters, P.S. (2006). “The Molecular Biology of Coronaviruses.”), 193-292.
  • Mcauliffe, M.E., and Perry, M.J. (2009). Are nanoparticles potential male reproductive toxicants? A literature review. Nanotoxicology 1, 204-210.
  • Mccullough, P.A., Alexander, P.E., Armstrong, R., Arvinte, C., Bain, A.F., Bartlett, R.P., et al. (2020). Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). Rev Cardiovasc Med 21, 517-530.
  • Mcewen, B.S. (2007). Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 87, 873-904.
  • Mcewen, B.S. (2017). Neurobiological and Systemic Effects of Chronic Stress. Chronic Stress (Thousand Oaks) 1.
  • Mcewen, B.S., Eiland, L., Hunter, R.G., and Miller, M.M. (2012). Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology 62, 3-12.
  • Merchant, H. (2021). Rapid Response: Autoimmune damage to the nerves following Covid vaccines: EMA issued warning to patients and healthcare professionals. BMJ 374.
  • Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E.J., Nadir, E., Olsha-Castell, S., Arad, D., Hasin, T., Levi, N., Asleh, R., Amir, O., Meir, K., Cohen, D., Dichtiar, R., Novick, D., Hershkovitz, Y., Dagan, R., Leitersdorf, I., Ben-Ami, R., Miskin, I., Saliba, W., Muhsen, K., Levi, Y., Green, M.S., Keinan-Boker, L., and Alroy-Preis, S. (2021). Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel. New England Journal of Medicine.
  • Miller, A.M. (2020). CDC director acknowledges hospitals have a monetary incentive to overcount coronavirus deaths. Washington Examiner.
  • Million, M., Lagier, J.C., Gautret, P., Colson, P., Fournier, P.E., Amrane, S., Hocquart, M., Mailhe, M., Esteves-Vieira, V., Doudier, B., Aubry, C., Correard, F., Giraud-Gatineau, A., Roussel, Y., Berenger, C., Cassir, N., et al. (2020). Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis 35, 101738.
  • Mizrahi, B., Lotan, R., Kalkstein, N., Peretz, A., Perez, G., Ben-Tov, A., Chodick, G., Gazit, S., and Patalon, T. (2021). Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine. Nat Commun 12, 6379.
  • Morin, C.M., and Carrier, J. (2021). The acute effects of the COVID-19 pandemic on insomnia and psychological symptoms. Sleep Med 77, 346-347.
  • National Center for Health Statistics (2020). “Guidance for Certifying Deaths Due to Coronavirus Disease 2019 (COVID–19)”. (Hyattsville, MD.).
  • Neupane, B.B., Mainali, S., Sharma, A., and Giri, B. (2019). Optical microscopic study of surface morphology and filtering efficiency of face masks. PeerJ 7, e7142.
  • Nogues, X., Ovejero, D., Pineda-Moncusi, M., Bouillon, R., Arenas, D., Pascual, J., Ribes, A., GuerriFernandez, R., Villar-Garcia, J., Rial, A., Gimenez-Argente, C., Cos, M.L., Rodriguez-Morera, J., Campodarve, I., Quesada-Gomez, J.M., and Garcia-Giralt, N. (2021). Calcifediol treatment and COVID19-related outcomes. J Clin Endocrinol Metab.
  • Nordström, P., Ballin, M., and Nordström, A. (2021). Effectiveness of Covid-19 Vaccination Against Risk of Symptomatic Infection, Hospitalization, and Death Up to 9 Months: A Swedish Total-Population Cohort Study. SSRN Electronic Journal.
  • O’driscoll, M., Ribeiro Dos Santos, G., Wang, L., Cummings, D.a.T., Azman, A.S., Paireau, J., Fontanet, A., Cauchemez, S., and Salje, H. (2021). Age-specific mortality and immunity patterns of SARS-CoV-2. Nature 590, 140-145.
  • Olivarria, G.M., Cheng, Y., Furman, S., Pachow, C., Hohsfield, L.A., Smith-Geater, C., Miramontes, R., Wu, J., Burns, M.S., Tsourmas, K.I., Stocksdale, J., Manlapaz, C., Yong, W.H., Teijaro, J., Edwards, R., Green, K.N., Thompson, L.M., and Lane, T.E. (2021). Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice.
  • Oller, J.W., Shaw, C.A., Tomljenovic, L., Karanja, S.K., Ngare, W., Clement, F.M., and Pillette, J.R. (2017). HCG Found in WHO Tetanus Vaccine in Kenya Raises Concern in the Developing World. OALib 04, 1-32.
  • Olliaro, P., Torreele, E., and Vaillant, M. (2021). COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room. The Lancet Microbe 2, e279-e280.
  • Opel, D.J., Diekema, D.S., and Ross, L.F. (2021). Should We Mandate a COVID-19 Vaccine for Children? JAMA Pediatr 175, 125-126.
  • Pal, R., Banerjee, M., Bhadada, S.K., Shetty, A.J., Singh, B., and Vyas, A. (2021). Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis. J Endocrinol Invest.
  • Palmer, G.G. (2021). “COVID-19 Reinfection and Transmission (IR# 0552)”, in: Freedom of Information Act Request. (New York, NY: Siri & Glimstad).
  • Pandey, S., Pathak, S.K., Pandey, A., Salunke, A.A., Chawla, J., Sharma, A., Sharma, S., Thivari, P., and Ratna, H.V.K. (2020). Ivermectin in COVID-19: What do we know? Diabetes Metab Syndr 14, 1921-1922.
  • Park, S.R., Han, J., Yeon, Y.M., Kang, N.Y., and Kim, E. (2021). Effect of face mask on skin characteristics changes during the COVID-19 pandemic. Skin Res Technol 27, 554-559.
  • Perlman, S., and Dandekar, A.A. (2005). Immunopathogenesis of coronavirus infections: implications for SARS. Nat Rev Immunol 5, 917-927.
  • Petrilli, C.M., Jones, S.A., Yang, J., Rajagopalan, H., O’donnell, L., Chernyak, Y., Tobin, K.A., Cerfolio, R.J., Francois, F., and Horwitz, L.I. (2020). Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 369, m1966.
  • Pfizer SARS-CoV-2 mRNA Vaccine (BNT162, PF-07302048).
  • Pollock, A.M., and Lancaster, J. (2020). Asymptomatic transmission of covid-19. Bmj-British Medical Journal 371, m4851.
  • Poon, M.M.L., Rybkina, K., Kato, Y., Kubota, M., Matsumoto, R., Bloom, N.I., Zhang, Z., Hastie, K.M., Grifoni, A., Weiskopf, D., Wells, S.B., Ural, B.B., Lam, N., Szabo, P.A., Dogra, P., Lee, Y.S., Gray, J.I., Bradley, M.C., Brusko, M.A., Brusko, T.M., Saphire, E.O., Connors, T.J., Sette, A., Crotty, S., and Farber, D.L. (2021). SARS-CoV-2 infection generates tissue-localized immunological memory in humans. Sci Immunol, eabl9105.
  • Pornhub (2020). Coronavirus insights [Online]. Available: https://www.pornhub.com/insights/coronavirusupdate-april-14 [Accessed 12/01/2020].
  • Qayyum, S., Mohammad, T., Slominski, R.M., Hassan, M.I., Tuckey, R.C., Raman, C., and Slominski, A.T. (2021). Vitamin D and lumisterol novel metabolites can inhibit SARS-CoV-2 replication machinery enzymes. Am J Physiol Endocrinol Metab 321, E246-E251.
  • Quesada-Gomez, J.M., Entrenas-Castillo, M., and Bouillon, R. (2020). Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166. J Steroid Biochem Mol Biol 202, 105719.
  • Rajkumar, R.P. (2020). COVID-19 and mental health: A review of the existing literature. Asian J Psychiatr 52, 102066.
  • Rajter, J.C., Sherman, M.S., Fatteh, N., Vogel, F., Sacks, J., and Rajter, J.J. (2021). Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study. Chest 159, 85-92.
  • Read, A.F., Baigent, S.J., Powers, C., Kgosana, L.B., Blackwell, L., Smith, L.P., Kennedy, D.A., WalkdenBrown, S.W., and Nair, V.K. (2015). Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens. PLoS Biol 13, e1002198.
  • Reynolds, D.L., Garay, J.R., Deamond, S.L., Moran, M.K., Gold, W., and Styra, R. (2008). Understanding, compliance and psychological impact of the SARS quarantine experience. Epidemiol Infect 136, 997-1007.
  • Richardson, B., and Bentley, S. (2020). The disruption and recovery of cancer from COVID-19: pathway, outcomes and restarting.
  • Richardson, S., Hirsch, J.S., Narasimhan, M., Crawford, J.M., Mcginn, T., Davidson, K.W., et al. (2020). Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 323, 2052-2059.
  • Ricke, D.O. (2021). Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies. Front Immunol 12, 640093.
  • Riemersma, K.K., Grogan, B.E., Kita-Yarbro, A., Halfmann, P.J., Segaloff, H.E., Kocharian, A., Florek, K.R., Westergaard, R., Bateman, A., Jeppson, G.E., Kawaoka, Y., O’connor, D.H., Friedrich, T.C., and Grande, K.M. (2021). Shedding of Infectious SARS-CoV-2 Despite Vaccination.
  • Riley, L.E. (2021). mRNA Covid-19 Vaccines in Pregnant Women. N Engl J Med 384, 2342-2343.
  • Roberge, R.J., Kim, J.H., and Coca, A. (2012). Protective facemask impact on human thermoregulation: an overview. Ann Occup Hyg 56, 102-112.
  • Rockefeller Foundation, and Global Business Network (2010). “Scenarios for the Future of Technology and International Development”.).
  • Rodda, L.B., Netland, J., Shehata, L., Pruner, K.B., Morawski, P.A., Thouvenel, C.D., Takehara, K.K., et al. (2021). Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell 184, 169-183 e117.
  • Rose, J., and Mccullough, P.A. (2021). A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products. Curr Probl Cardiol, 101011.
  • Rubin, R. (2021). Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines. JAMA.
  • Sabico, S., Enani, M.A., Sheshah, E., Aljohani, N.J., Aldisi, D.A., Alotaibi, N.H., Alshingetti, N., Alomar, S.Y., Alnaami, A.M., Amer, O.E., Hussain, S.D., and Al-Daghri, N.M. (2021). Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial. Nutrients 13.
  • Saito, A., Irie, T., Suzuki, R., Maemura, T., Nasser, H., Uriu, K., Kosugi, Y., Shirakawa, K., Sadamasu, K., et al. (2021). SARS-CoV-2 spike P681R mutation, a hallmark of the Delta variant, enhances viral fusogenicity and pathogenicity.
  • Savic, I., Heden-Blomqvist, E., and Berglund, H. (2009). Pheromone signal transduction in humans: what can be learned from olfactory loss. Hum Brain Mapp 30, 3057-3065.
  • Savulescu, J., and Cameron, J. (2020). Why lockdown of the elderly is not ageist and why levelling down equality is wrong. J Med Ethics 46, 717-721.
  • Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Chikkabyrappa, S.M., and Portman, M.A. (2021a). Myopericarditis after the Pfizer mRNA COVID-19 Vaccine in Adolescents. J Pediatr.
  • Schauer, S.G., Naylor, J.F., April, M.D., Carius, B.M., and Hudson, I.L. (2021). Analysis of the Effects of COVID-19 Mask Mandates on Hospital Resource Consumption and Mortality at the County Level. South Med J 114, 597-602.
  • Scheid, J.L., Lupien, S.P., Ford, G.S., and West, S.L. (2020). Commentary: Physiological and Psychological Impact of Face Mask Usage during the COVID-19 Pandemic. Int J Environ Res Public Health 17.
  • Schwarz, S., Jenetzky, E., Krafft, H., Maurer, T., and Martin, D. (2021). [Corona child studies “Co-Ki”: first results of a Germany-wide register on mouth and nose covering (mask) in children]. Monatsschr Kinderheilkd, 1-10.
  • Segerstrom, S.C., and Miller, G.E. (2004). Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 130, 601-630.
  • Servellita, V., Sotomayor-Gonzalez, A., Gliwa, A.S., Torres, E., Brazer, N., Zhou, A., Hernandez, K.T., Sankaran, M., Wang, B., Wong, D., Wang, C., Zhang, Y., Reyes, K.R., Glasner, D., Deng, X., Streithorst, J., Miller, S., Frias, E., Rodgers, M., Cloherty, G., Hackett, J., Philip, S., Topper, S., Sachdev, D., and Chiu, C.Y. (2021). Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.
  • Setia, R., Dogra, M., Handoo, A., Yadav, R., Thangavel, G.P., and Rahman, A.E. (2021). Use of face mask by blood donors during the COVID-19 pandemic: Impact on donor hemoglobin concentration: A bane or a boon. Transfus Apher Sci 60, 103160.
  • Sharun, K., Dhama, K., Patel, S.K., Pathak, M., Tiwari, R., Singh, B.R., Sah, R., Bonilla-Aldana, D.K., Rodriguez-Morales, A.J., and Leblebicioglu, H. (2020). Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19. Ann Clin Microbiol Antimicrob 19, 23.
  • Shenal, B.V., Radonovich, L.J., Jr., Cheng, J., Hodgson, M., and Bender, B.S. (2012). Discomfort and exertion associated with prolonged wear of respiratory protection in a health care setting. J Occup Environ Hyg 9, 59-64.
  • Shimabukuro, T.T., Kim, S.Y., Myers, T.R., Moro, P.L., Oduyebo, T., Panagiotakopoulos, L., Marquez, P.L., Olson, C.K., Liu, R., Chang, K.T., Ellington, S.R., Burkel, V.K., Smoots, A.N., Green, C.J., Licata, C., Zhang, B.C., Alimchandani, M., Mba-Jonas, A., Martin, S.W., Gee, J.M., Meaney-Delman, D.M., and Team, C.D.C.V.-S.C.-P.R. (2021). Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N Engl J Med 384, 2273-2282.
  • Singh, A.K., Singh, A., Singh, R., and Misra, A. (2020). Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies. Diabetes Metab Syndr 14, 641-648.
  • Slavova, S., Rock, P., Bush, H.M., Quesinberry, D., and Walsh, S.L. (2020). Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug Alcohol Depend 214, 108176.
  • Sommershof, A., Scheuermann, L., Koerner, J., and Groettrup, M. (2017). Chronic stress suppresses anti-tumor TCD8+ responses and tumor regression following cancer immunotherapy in a mouse model of melanoma. Brain Behav Immun 65, 140-149.
  • Strauss, R., Jawhari, N., Attaway, A.H., Hu, B., Jehi, L., Milinovich, A., Ortega, V.E., and Zein, J.G. (2021). Intranasal Corticosteroids Are Associated with Better Outcomes in Coronavirus Disease 2019. J Allergy Clin Immunol Pract.
  • Subramanian, S.V., and Kumar, A. (2021). Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States. Eur J Epidemiol.
  • Sud, A., Jones, M.E., Broggio, J., Loveday, C., Torr, B., Garrett, A., Nicol, D.L., Jhanji, S., Boyce, S.A., Gronthoud, F., Ward, P., Handy, J.M., Yousaf, N., Larkin, J., Suh, Y.E., Scott, S., Pharoah, P.D.P., Swanton, C., Abbosh, C., Williams, M., Lyratzopoulos, G., Houlston, R., and Turnbull, C. (2020). Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann Oncol 31, 1065-1074.
  • Suzuki, Y.J., and Gychka, S.G. (2021). SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines. Vaccines (Basel) 9.
  • Talotta, R. (2021). Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”. Clin Immunol 224, 108665.
  • Talwar, G.P., and Raghupathy, R. (1989). Anti-fertility vaccines. Vaccine 7, 97-101.
  • Tan, C.W., Ho, L.P., Kalimuddin, S., Cherng, B.P.Z., Teh, Y.E., Thien, S.Y., Wong, H.M., Tern, P.J.W., Chandran, M., Chay, J.W.M., Nagarajan, C., Sultana, R., Low, J.G.H., and Ng, H.J. (2020). Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition 79-80, 111017.
  • Tang, Y., Liu, J., Zhang, D., Xu, Z., Ji, J., and Wen, C. (2020). Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies. Front Immunol 11, 1708.
  • Tay, M.Z., Poh, C.M., Renia, L., Macary, P.A., and Ng, L.F.P. (2020). The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 20, 363-374.
  • Temple, C., Hoang, R., and Hendrickson, R.G. (2021). Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19. New England Journal of Medicine.
  • Teshome, A., Adane, A., Girma, B., and Mekonnen, Z.A. (2021). The Impact of Vitamin D Level on COVID19 Infection: Systematic Review and Meta-Analysis. Front Public Health 9, 624559.
  • Thacker, P.D. (2021). Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial. Bmj.
  • Thomas, S.J., Moreira, E.D., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J.L., et al. (2021). Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine.
  • Tong, P.S., Kale, A.S., Ng, K., Loke, A.P., Choolani, M.A., Lim, C.L., Chan, Y.H., Chong, Y.S., Tambyah, P.A., and Yong, E.L. (2015). Respiratory consequences of N95-type Mask usage in pregnant healthcare workers-a controlled clinical study. Antimicrob Resist Infect Control 4, 48.
  • Troeger, C., Blacker, B.F., Khalil, I.A., Rao, P.C., Cao, S., Zimsen, S.R.M., Albertson, S.B., et al. (2018). Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Infectious Diseases 18, 1211-1228.
  • Tseng, C.T., Sbrana, E., Iwata-Yoshikawa, N., Newman, P.C., Garron, T., Atmar, R.L., Peters, C.J., and Couch, R.B. (2012). Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLoS One 7, e35421.
  • Turner, J.S., Kim, W., Kalaidina, E., Goss, C.W., Rauseo, A.M., Schmitz, A.J., Hansen, L., Haile, A., Klebert, M.K., Pusic, I., O’halloran, J.A., Presti, R.M., and Ellebedy, A.H. (2021). SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature 595, 421-425.
  • U.S. Food and Drug Administration (2020). “Long Term Follow-Up After Administration of Human Gene Therapy Products – Guidance for Industry”.).
  • Uk Health Security Agency (2021). COVID-19 vaccine surveillance report – Week 42.
  • Ussai, S., Armocida, B., Formenti, B., Palestra, F., Calvi, M., and Missoni, E. (2020). Hazard Prevention, Death and Dignity During COVID-19 Pandemic in Italy. Front Public Health 8, 509.
  • Viera, A.J. (2008). Odds ratios and risk ratios: what’s the difference and why does it matter? South Med J 101, 730-734.
  • Vincent, M.J., Bergeron, E., Benjannet, S., Erickson, B.R., Rollin, P.E., Ksiazek, T.G., Seidah, N.G., and Nichol, S.T. (2005). Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2, 69.
  • Vinod, N. (2020). Identifying patterns in COVID-19: Morbidity, recovery and the aftermath. International Journal of Clinical Virology 4, 056-064.
  • Vitale, J., Mumoli, N., Clerici, P., De Paschale, M., Evangelista, I., Cei, M., and Mazzone, A. (2021). Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy. JAMA Intern Med 181, 1407-1408.
  • Vojdani, A., and Kharrazian, D. (2020). Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol 217, 108480.
  • Vora, A., Arora, V.K., Behera, D., and Tripathy, S.K. (2020). White paper on Ivermectin as a potential therapy for COVID-19. Indian J Tuberc 67, 448-451.
  • Wahl, A., Gralinski, L.E., Johnson, C.E., Yao, W., Kovarova, M., Dinnon, K.H., 3rd, Liu, H., Madden, V.J., Krzystek, H.M., De, C., White, K.K., Gully, K., Schafer, A., Zaman, T., Leist, S.R., Grant, P.O., Bluemling, G.R., Kolykhalov, A.A., Natchus, M.G., Askin, F.B., Painter, G., Browne, E.P., Jones, C.D., Pickles, R.J., Baric, R.S., and Garcia, J.V. (2021). SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801. Nature 591, 451-457.
  • Walach, H., Klement, R.J., and Aukema, W. (2021a). The Safety of COVID-19 Vaccinations — Should We Rethink the Policy? Science, Public Health Policy and the Law 3, 87-99.
  • Walach, H., Weikl, R., Prentice, J., Diemer, A., Traindl, H., Kappes, A., and Hockertz, S. (2021b). Experimental Assessment of Carbon Dioxide Content in Inhaled Air With or Without Face Masks in Healthy Children: A Randomized Clinical Trial. JAMA Pediatr.
  • Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., and Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30, 269-271.
  • Wang, R., Song, B., Wu, J., Zhang, Y., Chen, A., and Shao, L. (2018). Potential adverse effects of nanoparticles on the reproductive system. Int J Nanomedicine 13, 8487-8506.
  • Wang, Z., Muecksch, F., Schaefer-Babajew, D., Finkin, S., Viant, C., Gaebler, C., Hoffmann, H.H., Barnes, C.O., Cipolla, M., Ramos, V., Oliveira, T.Y., Cho, A., Schmidt, F., Da Silva, J., Bednarski, E., Aguado, L., et al. (2021). Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature 595, 426-431.
  • Wang, Z., Xiong, G., Tsang, W.C., Schatzlein, A.G., and Uchegbu, I.F. (2019). Nose-to-Brain Delivery. J Pharmacol Exp Ther 370, 593-601.
  • Weber, A., Willeke, K., Marchloni, R., Myojo, T., Mckay, R., Donnelly, J., and Liebhaber, F. (1993). Aerosol penetration and leakae characteristics of masks used in the health care industry. American Journal of Infection Control 21, 167-173.
  • Who (2020). International Guidelines for Certification and Classification (Coding) of COVID-19 as Cause of Death.
  • Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., Grinberg, T., Auster, O., Dagan, N., Balicer, R.D., and Kornowski, R. (2021). Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. New England Journal of Medicine.
  • Wolff, G.G. (2020). Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season. Vaccine 38, 350-354.
  • Wu, F., Yan, R., Liu, M., Liu, Z., Wang, Y., Luan, D., Wu, K., Song, Z., Sun, T., Ma, Y., Zhang, Y., Wang, Q., Li, X., Ji, P., Li, Y., Li, C., Wu, Y., Ying, T., Wen, Y., Jiang, S., Zhu, T., Lu, L., Zhang, Y., Zhou, Q., and Huang, J. (2020). Antibody-dependent enhancement (ADE) of SARS-CoV-2 infection in recovered COVID-19 patients: studies based on cellular and structural biology analysis.
  • Xiao, J., Shiu, E.Y.C., Gao, H., Wong, J.Y., Fong, M.W., Ryu, S., and Cowling, B.J. (2020). Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-Personal Protective and Environmental Measures. Emerg Infect Dis 26, 967-975.
  • Xue, J., Moyer, A., Peng, B., Wu, J., Hannafon, B.N., and Ding, W.Q. (2014). Chloroquine is a zinc ionophore. PLoS One 9, e109180.
  • Ye, Q., Wang, B., and Mao, J. (2020). The pathogenesis and treatment of the `Cytokine Storm’ in COVID-19. J Infect 80, 607-613.
  • Zabetakis, I., Lordan, R., Norton, C., and Tsoupras, A. (2020). COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation. Nutrients 12.
  • Zaidi, A.K., and Dehgani-Mobaraki, P. (2021). The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article. J Antibiot (Tokyo).
  • Zhang, J., Lin, H., Ye, B., Zhao, M., Zhan, J., Dong, S., Guo, Y., Zhao, Y., Li, M., Liu, S., Zhang, H., Xiao, W., Guo, Y., Yue, C., Zhang, D., Yang, M., Zhang, J., Quan, C., Shi, W., Liu, X., Liu, P., Jiang, Y., Wu, G., Gao, G.F., and Liu, W.J. (2021). One-year sustained cellular and humoral immunities of COVID-19 convalescents. Clin Infect Dis.
  • Zhang, L., Richards, A., Barrasa, M.I., Hughes, S.H., Young, R.A., and Jaenisch, R. (2021b). Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proc Natl Acad Sci U S A 118.
  • Zhang, L., Zhou, L., Bao, L., Liu, J., Zhu, H., Lv, Q., Liu, R., Chen, W., Tong, W., Wei, Q., Xu, Y., Deng, W., Gao, H., Xue, J., Song, Z., Yu, P., Han, Y., Zhang, Y., Sun, X., Yu, X., and Qin, C. (2021c). SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct Target Ther 6, 337.
  • Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., and Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054-1062.
  • Zuo, J., Dowell, A.C., Pearce, H., Verma, K., Long, H.M., Begum, J., Aiano, F., Amin-Chowdhury, Z., Hoschler, K., Brooks, T., Taylor, S., Hewson, J., Hallis, B., Stapley, L., Borrow, R., Linley, E., Ahmad, S., Parker, B., Horsley, A., Amirthalingam, G., Brown, K., Ramsay, M.E., Ladhani, S., and Moss, P. (2021). Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection. Nat Immunol 22, 620-626.